233
Views
1
CrossRef citations to date
0
Altmetric
Polycystic ovary syndrome

Usage of mobile health interventions among overweight/obese PCOS patients undergoing assisted reproductive technology treatment during the COVID-19 pandemic

, , , , , , & show all
Pages 776-780 | Received 25 May 2022, Accepted 31 Jul 2022, Published online: 21 Aug 2022

References

  • Park CH, Chun S. Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndrome. Obstet Gynecol Sci. 2016;59(6):498–505.
  • Li H, Li L, Gu J, et al. Should all women with polycystic ovary syndrome be screened for metabolic parameters?: a Hospital-Based observational study. PLoS One. 2016;11(11):e0167036.
  • Rotterdam EA-S. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
  • Chun S. Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Mullerian hormone level is related to ovarian volume in korean women with polycystic ovary syndrome. Clin Exp Reprod Med. 2014;41(2):86–91.
  • Duică F, Dănilă CA, Boboc AE, et al. Impact of increased oxidative stress on cardiovascular diseases in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:614679.
  • Chaudhary H, Patel J, Jain NK, et al. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis. J Ovarian Res. 2021;14(1):125.
  • Akpinar F, Dilbaz B, Cirik DA, et al. The significance of anthropometric and endocrine parameters in ovulation induction with clomiphene citrate in women with polycystic ovary syndrome. Saudi Med J. 2016;37(11):1272–1275.
  • Zhang Z, Sang M, Liu S, et al. Differential expression of long non-coding RNA regulator of reprogramming and its molecular mechanisms in polycystic ovary syndrome. J Ovarian Res. 2021;14(1):79.
  • Chen X, Koivuaho E, Piltonen TT, et al. Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring: a population-based cohort study. Hum Reprod. 2021;36(8):2345–2357.
  • Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the amsterdam ESHRE/ASRM-Sponsored 3rd PCOS consensus workshop group. Fertil Steril. 2012;97(1):28–38 e25.
  • Aladashvili-Chikvaidze N, Kristesashvili J, Gegechkori M. Types of reproductive disorders in underweight and overweight young females and correlations of respective hormonal changes with BMI. Iran J Reprod Med. 2015;13(3):135–140.
  • Niu Z, Lin N, Gu R, et al. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J Clin Endocrinol Metab. 2014;99(11):E2269–76.
  • AlHussain F, AlRuthia Y, Al-Mandeel H, et al. Metformin improves the depression symptoms of women with polycystic ovary syndrome in a lifestyle modification program. Patient Prefer Adherence. 2020;14:737–746.
  • Shen W, Zhang Y, Li W, et al. Effects of tanshinone on hyperandrogenism and the quality of life in women with polycystic ovary syndrome: protocol of a double-blind, placebo-controlled, randomised trial. BMJ Open. 2013;3(10):e003646.
  • Pirotta S, Joham AJ, Moran LJ, et al. Implementation of evidence-based PCOS lifestyle management guidelines: perceived barriers and facilitators by consumers using the theoretical domains framework and COM-B model. Patient Educ Couns. 2021;104(8):2080–2088.
  • Pina IL, Allen LA, Desai NR. Managing the economic challenges in the treatment of heart failure. BMC Cardiovasc Disord. 2021;21(1):612.
  • Issom DZ, Hardy-Dessources MD, Romana M, et al. Toward a conversational agent to support the self-management of adults and young adults with sickle cell disease: usability and usefulness study. Front Digit Health. 2021;3:600333.
  • Shen YT, Chen L, Yue WW, et al. Digital technology-based telemedicine for the COVID-19 pandemic. Front Med (Lausanne). 2021;8:646506.
  • Sayed GA, Al-Sawaf HA, Al-Sawaf AH, et al. Mitochondrial DNA in fresh versus frozen embryo culture media of polycystic ovarian syndrome patients undergoing invitro fertilization: a possible predictive marker of a successful pregnancy. Pharmgenomics Pers Med. 2021;14:27–38.
  • Li J, Chen H, Gou M, et al. Molecular features of polycystic ovary syndrome revealed by transcriptome analysis of oocytes and cumulus cells. Front Cell Dev Biol. 2021;9:735684.
  • Liu Q, Li Y, Feng Y, et al. Single-cell analysis of differences in transcriptomic profiles of oocytes and cumulus cells at GV, MI, MII stages from PCOS patients. Sci Rep. 2016;6:39638.
  • Consultation WHOE. Appropriate body-mass index for asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163.
  • Lim S, Smith CA, Costello MF, et al. Barriers and facilitators to weight management in overweight and obese women living in Australia with PCOS: a qualitative study. BMC Endocr Disord. 2019;19(1):106.
  • Fu XJ, Hu SD, Peng YF, et al. Observation of the effect of one-to-one education on high-risk cases of diabetic foot. World J Clin Cases. 2021;9(14):3265–3272.
  • Zhai Y, Pang Y. Systemic and ovarian inflammation in women with polycystic ovary syndrome. J Reprod Immunol. 2022;151:103628.
  • Lin AW, Bergomi EJ, Dollahite JS, et al. Trust in physicians and medical experience beliefs differ between women with and without polycystic ovary syndrome. J Endocr Soc. 2018;2(9):1001–1009.
  • Bagheri H, Shakeri S, Nazari AM, et al. Effectiveness of nurse-led counselling and education on self-efficacy of patients with acute coronary syndrome: a randomized controlled trial. Nurs Open. 2022;9(1):775–784.
  • Wang L, Liu Y, Tan H, et al. Transtheoretical model-based mobile health application for PCOS. Reprod Health. 2022;19(1):117.
  • Chen J, Ho E, Jiang Y, et al. A mobile social Network-Based smoking cessation intervention for chinese male smokers: Protocol for a pilot randomized controlled trial. JMIR Res Protoc. 2020;9(9):e18071.
  • Gesesew HA, Koye DN, Fetene DM, et al. Risk factors for COVID-19 infection, disease severity and related deaths in africa: a systematic review. BMJ Open. 2021;11(2):e044618.
  • Chen H, Shi L, Zhang Y, et al. A cross-country core strategy comparison in China, Japan, Singapore and South Korea during the early COVID-19 pandemic. Global Health. 2021;17(1):22.
  • Cincione RI, Losavio F, Ciolli F, et al. Effects of mixed of a ketogenic diet in overweight and obese women with polycystic ovary syndrome. Int J Environ Res Public Health. 2021;18(23):12490.
  • Kamardi S, Surya IHW, Mahendra INB, et al. Impact of body mass index on intracytoplasmic sperm injection in women with polycystic ovary syndrome. Zygote. 2021;29(3):229–233.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.